Owkin has 6 close competitors: Doctolib, Abridge, Alloy Therapeutics, Baylor Genetics.
Sector, valuation and status for each competitor.
A private valuation and a public market cap share one column; each row names its basis and date.
Owkin
Doctolib
Abridge
Arthrex
BenchlingBiotech AI company developing K Pro, an autonomous AI scientist for pharmaceutical R&D and clinical research, analyzing multimodal patient data for drug discovery
Owkin competes with 6 companies here: Doctolib, Abridge, Alloy Therapeutics, Arthrex, Benchling, Baylor Genetics.
The closest biotech / ai peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Owkin is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
